Home › Calculator › BJDX Dividend Calculator 2026
BJDX Dividend DRIP Calculator 2026
156.25% YieldHealthcareBluejay Diagnostics, Inc. · NASDAQ
Price: $1.28 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When BJDX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your BJDX snowball 📈
$10,000 in BJDX → $122.08M in 10 years · $6,203,169.48/month
About Bluejay Diagnostics, Inc. (BJDX) — Dividend Analysis 2026
Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force. It also includes the Symphony Cartridge, which comes pre-loaded with essential reagents and components. The company additionally provides the ALLEREYE diagnostic test, a convenient, on-site device for quickly identifying allergic conjunctivitis. Bluejay Diagnostics is also progressing with the development of Symphony IL-6 tests, intended for monitoring disease advancement in critical care environments. Furthermore, they are actively creating additional diagnostic tests for their Symphony platform, such as those aimed at detecting myocardial infarction (heart attack) and congestive heart failure. Bluejay Diagnostics, Inc. was founded in 2015 and is headquartered in Acton, Massachusetts.
Compare BJDX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full BJDX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BJDX position with:
🌍 BJDX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold BJDX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 156.25% | 153.45% | $15,625 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 132.81% | 130.01% | $13,281 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 125.00% | 122.20% | $12,500 / yr |
| 🇬🇧 UK ISA | 0% | 156.25% | 153.45% | $15,625 / yr |
| 🇬🇧 UK Taxable | 8.75% | 142.58% | 139.78% | $14,258 / yr |
| 🇨🇦 TFSA | 0% | 156.25% | 153.45% | $15,625 / yr |
| 🇨🇦 CA Taxable | 25% | 117.19% | 114.39% | $11,719 / yr |
| 🇦🇺 Super (pension) | 15% | 132.81% | 130.01% | $13,281 / yr |
| 🇦🇺 AU Taxable | 30% | 109.38% | 106.58% | $10,938 / yr |
| 🇩🇪 DE Taxable | 26.375% | 115.04% | 112.24% | $11,504 / yr |
| 🇫🇷 FR Taxable | 30% | 109.38% | 106.58% | $10,938 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 BJDX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 BJDX Dividend Payment Schedule
BJDX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 BJDX vs Healthcare Benchmarks
How BJDX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BJDX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ BJDX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2026-07-09 | 64,047 | $1.51 | $96.7K | ||
| Sale | 2026-07-10 | 34,938 | $1.40 | $48.9K | ||
| Buy | 2026-03-14 | 12,500 | $2.00 | $25.0K | ||
| Buy | 2026-03-14 | 12,500 | $2.00 | $25.0K | ||
| Buy | 2026-03-14 | 12,500 | $2.00 | $25.0K | ||
| Buy | 2026-03-14 | 12,500 | $2.00 | $25.0K | ||
| Buy | 2026-03-14 | 12,500 | $2.00 | $25.0K | ||
| Buy | 2023-12-13 | 500 | $3.07 | $1.5K | ||
| Buy | 2023-12-13 | 500 | $3.27 | $1.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BJDX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Bluejay Diagnostics, Inc. (BJDX) is currently trading at $1.28, 100% below its 52-week high. The current dividend yield is 156.25% based on an annual payout of $2.00 per share.
BJDX (Bluejay Diagnostics, Inc.) — 156.25% Dividend Yield Analysis
Bluejay Diagnostics, Inc. (BJDX) is a healthcare stock currently trading at $1.28 with a dividend yield of 156.25%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (156.25%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest BJDX News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.